Social Smoking Environment and Associations With Cardiac Rehabilitation Attendance.


Journal

Journal of cardiopulmonary rehabilitation and prevention
ISSN: 1932-751X
Titre abrégé: J Cardiopulm Rehabil Prev
Pays: United States
ID NLM: 101291247

Informations de publication

Date de publication:
01 01 2021
Historique:
pubmed: 15 9 2020
medline: 3 11 2021
entrez: 14 9 2020
Statut: ppublish

Résumé

Continued cigarette smoking after a major cardiac event predicts worse health outcomes and leads to reduced participation in cardiac rehabilitation (CR). Understanding which characteristics of current smokers are associated with CR attendance and smoking cessation will help improve care for these high-risk patients. We examined whether smoking among social connections was associated with CR participation and continued smoking in cardiac patients. Participants included 149 patients hospitalized with an acute cardiac event who self-reported smoking prior to the hospitalization and were eligible for outpatient CR. Participants completed a survey on their smoking habits prior to hospitalization and 3 mo later. Participants were dichotomized into two groups by the proportion of friends or family currently smoking ("None-Few" vs "Some-Most"). Sociodemographic, health, secondhand smoke exposure, and smoking measures were compared using t tests and χ2 tests (P < .05). ORs were calculated to compare self-reported rates of CR attendance and smoking cessation at 3-mo follow-up. Compared with the "None-Few" group, participants in the "Some-Most" group experienced more secondhand smoke exposure (P < .01) and were less likely to attend CR at follow-up (OR = 0.40; 95% CI, 0.17-0.93). Participants in the "Some-Most" group tended to be less likely to quit smoking, but this difference was not statistically significant. Social environments with more smokers predicted worse outpatient CR attendance. Clinicians should consider smoking within the social network of the patient as an important potential barrier to pro-health behavior change.

Identifiants

pubmed: 32925296
pii: 01273116-202101000-00009
doi: 10.1097/HCR.0000000000000518
pmc: PMC7755730
mid: NIHMS1579990
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-51

Subventions

Organisme : NIDA NIH HHS
ID : U54 DA036114
Pays : United States
Organisme : NHLBI NIH HHS
ID : R33 HL143305
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007242
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103644
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR003168
Pays : United States

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Am J Cardiol. 2014 Jun 15;113(12):1933-40
pubmed: 24793668
Clin Cardiol. 2019 Dec;42(12):1189-1194
pubmed: 31647127
Eur J Prev Cardiol. 2020 Jun;27(9):912-928
pubmed: 31581808
Eur J Cardiovasc Nurs. 2019 Jan;18(1):38-47
pubmed: 29909641
Int J Public Health. 2015 Dec;60(8):891-899
pubmed: 26321106
Prev Med. 2018 Dec;117:76-82
pubmed: 29746974
Int J Cardiol. 2016 Nov 15;223:436-443
pubmed: 27557484
JAMA. 1993 Jan 13;269(2):232-6
pubmed: 8417241
Nicotine Tob Res. 2004 Dec;6 Suppl 3:S363-9
pubmed: 15799599
Mayo Clin Proc. 2017 Feb;92(2):234-242
pubmed: 27855953
BMC Public Health. 2016 Jul 29;16:657
pubmed: 27473458
MMWR Morb Mortal Wkly Rep. 2018 Nov 09;67(44):1225-1232
pubmed: 30408019
Addiction. 2017 Mar;112(3):388-395
pubmed: 27503776
Ann Behav Med. 2020 Feb 21;54(3):141-150
pubmed: 31612218
JAMA. 2013 Apr 17;309(15):1613-21
pubmed: 23592106
Public Health Nurs. 2016 Jan-Feb;33(1):82-9
pubmed: 26010045
J Am Coll Cardiol. 2015 Aug 4;66(5):592-3
pubmed: 26227200
Eur J Prev Cardiol. 2014 Jun;21(6):767-73
pubmed: 22952289
N Engl J Med. 2001 Sep 20;345(12):892-902
pubmed: 11565523
MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1226-8
pubmed: 19008791
MMWR Morb Mortal Wkly Rep. 2013 Feb 8;62(5):81-7
pubmed: 23388551
Tob Control. 2006 Jun;15 Suppl 3:iii83-94
pubmed: 16754952
J Adolesc Health. 2017 Sep;61(3):363-370
pubmed: 28318910
Circulation. 2010 Feb 16;121(6):750-8
pubmed: 20124123
J Gen Intern Med. 2017 Sep;32(9):974-980
pubmed: 28470547
J Am Coll Cardiol. 2016 Jan 5;67(1):1-12
pubmed: 26764059
Prev Med. 2015 Nov;80:67-74
pubmed: 25900804
Eur Heart J. 2014 Mar;35(9):590-8
pubmed: 24334711
JAMA. 1995 Jul 12;274(2):155-60
pubmed: 7596004
Int J Environ Res Public Health. 2019 Mar 21;16(6):
pubmed: 30901920
Ann Intern Med. 1994 Feb 15;120(4):287-93
pubmed: 8291821
Thorax. 2011 Oct;66(10):847-55
pubmed: 21325144
Prev Med. 2019 Nov;128:105757
pubmed: 31254538
Cochrane Database Syst Rev. 2012 May 16;(5):CD001837
pubmed: 22592676
JAMA. 2014 Jan 8;311(2):172-82
pubmed: 24399556
Eur J Prev Cardiol. 2020 Mar;27(5):478-489
pubmed: 31597473
Prev Med. 2016 Nov;92:160-168
pubmed: 27090919
Neurology. 2017 Oct 17;89(16):1723-1729
pubmed: 28887378
Addiction. 2010 Jun;105(6):1100-8
pubmed: 20331572
Arch Intern Med. 2000 Apr 10;160(7):939-44
pubmed: 10761958
J Am Coll Cardiol. 2018 Dec 25;72(25):3332-3365
pubmed: 30527452
Prev Med. 2019 Jan;118:51-58
pubmed: 30316877
Psychol Addict Behav. 2014 Dec;28(4):1144-52
pubmed: 24841185
Addiction. 2011 Dec;106(12):2110-21
pubmed: 21752135
Nicotine Tob Res. 2010 Oct;12 Suppl:S45-50
pubmed: 20889480
J Am Coll Cardiol. 2019 Jul 30;74(4):498-507
pubmed: 31345423
Int J Environ Res Public Health. 2018 Dec 31;16(1):
pubmed: 30602668
J Cardiopulm Rehabil Prev. 2019 May;39(3):181-186
pubmed: 31022000
Am J Med. 2000 Jul;109(1):20-6
pubmed: 10936474
J Cardiopulm Rehabil Prev. 2017 Mar;37(2):103-110
pubmed: 28033166
Am Heart J. 2012 Jan;163(1):81-87.e1
pubmed: 22172440
Addict Behav. 2015 Aug;47:22-32
pubmed: 25863004
J Cardiopulm Rehabil Prev. 2018 Sep;38(5):286-290
pubmed: 29120970
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
J Prim Prev. 2010 Aug;31(4):191-208
pubmed: 20614184
Prev Med. 2015 Dec;81:16-41
pubmed: 26190368

Auteurs

Hypatia A Bolívar (HA)

Vermont Center on Behavior and Health (Drs Bolívar, Ades, and Gaalema, Ms Elliott, and Mr Middleton) and Departments of Psychiatry (Drs Bolívar and Gaalema and Ms Elliott) and Psychology (Mr Middleton and Dr Gaalema), University of Vermont, Burlington; Departments of Psychiatry and Behavioural Sciences (Dr Yoon and Ms Haliwa) and Cardiothoracic and Vascular Surgery (Dr Miller), University of Texas Health Science at Houston; College of Nursing, University of Kentucky, Lexington (Dr Okoli); and Division of Cardiology, University of Vermont College of Medicine, Burlington (Dr Ades).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH